Thomas Koeglsperger

Thomas Köglsperger, MD, MHBA is a neurologist and clinician-scientist at LMU University Hospital Munich, Germany, where he serves as Senior Consultant Neurologist and leads the Deep Brain Stimulation and Parkinson’s Disease Complex Treatment Programs. Following his medical training at the University of Freiburg and doctoral research at Johannes Gutenberg University Mainz, he completed postdoctoral training at Harvard Medical School. His research focuses on the molecular and cellular mechanisms of neurodegenerative diseases, particularly early pathogenic processes in Parkinson’s disease and related synucleinopathies. By integrating experimental neuroscience, human neuropathology, and multi-omics approaches, his work aims to identify novel biomarkers and therapeutic targets for disease modification. His clinical and translational research focuses on precision neuromodulation, digital biomarkers, and patient-centered treatment strategies. He founded ParkLink, a telemedicine network for Pa